Sangamo TherapeuticsSGMOQ
13F holders, Q2 2026 (June 30)6holders −106
2new positions
106sold out
$0.05avg. 13F price*
At the end of Q2 2026, 6 institutions reported holding Sangamo Therapeutics Inc. (SGMOQ) in their 13F filings, down 106 from Q1 2026. 2 opened new positions and 106 sold out. The largest holders were Nomura Asset Management International Inc. ($22K), Simplex Trading, LLC ($4K) and Axiom Investment Management LLC ($1K).
- Company
- Sangamo Therapeutics Inc.
- CUSIP
- 800677106
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2026 → Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $5K |
| Exits | 106 | $25.9M |
All 13F filers, Q1 2026 → Q2 2026: 86,534 shares bought and 104,884,108 shares sold, net −104,797,574 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 6 holders
| Nomura Asset Management International Inc. | 0.00% | No change | 400,000 | $22K |
| Simplex Trading, LLC | 0.00% | New | 76,500 | $4K |
| Axiom Investment Management LLC | 0.00% | No change | 25,375 | $1K |
| Flow Traders U.S. LLC | 0.00% | Add +0.2% | 21,532 | $1K |
| Heritage Investment Group, Inc. | 0.00% | New | 10,000 | $539 |
| Barclays PLC | 0.00% | No change | 1 | $0 |
"% of holder's portfolio" is SGMOQ's weight in each manager's 13F, not the share of Sangamo Therapeutics Inc. the manager owns.